Pub Date : 2025-12-01Epub Date: 2025-07-02DOI: 10.1007/s13224-025-02139-z
Matteo Terrinoni, Federica Adinolfi, Angelo Baldoni, Dario Rossetti, Gian Carlo Di Renzo
Background: Lipschütz's acute vulvar ulceration is the vulvar manifestation of a systemic pathology. It is first reported in 1912 and is a non-sexually acquired condition characterized by symmetrical genital ulcers. It is an underdiagnosed condition with poor cases described in the literature. The main symptom is pain.
Case presentation: We describe the case report of a 14-year-old patient with painful genital ulcers associated with flu-like symptoms. The gynaecological examination showed the presence of multiple vulvar lesions. The diagnosis of Lipschütz ulcers was a diagnosis of exclusion.
Conclusion: This rare condition must not be underestimated because of any psychophysical implication. It is mandatory to reassure the patient and her family of its benign course.
{"title":"Lipschütz Ulcer: EBV or Mycoplasma?","authors":"Matteo Terrinoni, Federica Adinolfi, Angelo Baldoni, Dario Rossetti, Gian Carlo Di Renzo","doi":"10.1007/s13224-025-02139-z","DOIUrl":"10.1007/s13224-025-02139-z","url":null,"abstract":"<p><strong>Background: </strong>Lipschütz's acute vulvar ulceration is the vulvar manifestation of a systemic pathology. It is first reported in 1912 and is a non-sexually acquired condition characterized by symmetrical genital ulcers. It is an underdiagnosed condition with poor cases described in the literature. The main symptom is pain.</p><p><strong>Case presentation: </strong>We describe the case report of a 14-year-old patient with painful genital ulcers associated with flu-like symptoms. The gynaecological examination showed the presence of multiple vulvar lesions. The diagnosis of Lipschütz ulcers was a diagnosis of exclusion.</p><p><strong>Conclusion: </strong>This rare condition must not be underestimated because of any psychophysical implication. It is mandatory to reassure the patient and her family of its benign course.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 6","pages":"514-516"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12748456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-06-04DOI: 10.1007/s13224-025-02156-y
Dhanya R Shenoy, Rajalakshmi Ananthanarayanan, Vettakkara Kandy Muhammed Niyas, Vidyalekshmy R, Brinda Sabu, Sajith Mohan
Background: Zika virus (ZIKV), a mosquito-borne flavivirus, has emerged as a significant global health concern due to its potential adverse effects on maternal and fetal health. Severe fetal abnormalities, such as microcephaly, were notably linked to previous ZIKV outbreaks, particularly in Brazil. However, the correlation between ZIKV and congenital anomalies in India remains inconclusive.
Study: This case series retrospectively analysed pregnant women diagnosed with Zika virus disease (ZVD) at KIMSHEALTH, Thiruvananthapuram, from 2021 to 2024. ZIKV infection was confirmed via ZIKV RT-PCR testing on patient samples.The study identified ten confirmed cases of ZVD in pregnant women. Clinical presentations included maculopapular rash (in all patients), fever, joint pain, non-purulent conjunctivitis, and myalgia. Among these, two infections near term resulted in normal fetal outcomes, one mid-trimester infection led to a normal delivery, six women opted for medical termination of pregnancy (MTP), and one woman experienced a miscarriage.
Conclusion: The clinical features of ZVD during pregnancy observed in this cohort were similar to those in the general population. The absence of congenital anomalies suggests a potentially less pathogenic strain of ZIKV in India. However, further studies involving larger populations are required to conclusively determine the risk of congenital Zika syndrome in this region. This study underscores the need for ongoing surveillance and research to fully understand the impact of ZIKV on pregnancy in India.
{"title":"Zika Virus Disease in Pregnancy: A Case Series from the Kerala Outbreak.","authors":"Dhanya R Shenoy, Rajalakshmi Ananthanarayanan, Vettakkara Kandy Muhammed Niyas, Vidyalekshmy R, Brinda Sabu, Sajith Mohan","doi":"10.1007/s13224-025-02156-y","DOIUrl":"https://doi.org/10.1007/s13224-025-02156-y","url":null,"abstract":"<p><strong>Background: </strong>Zika virus (ZIKV), a mosquito-borne flavivirus, has emerged as a significant global health concern due to its potential adverse effects on maternal and fetal health. Severe fetal abnormalities, such as microcephaly, were notably linked to previous ZIKV outbreaks, particularly in Brazil. However, the correlation between ZIKV and congenital anomalies in India remains inconclusive.</p><p><strong>Study: </strong>This case series retrospectively analysed pregnant women diagnosed with Zika virus disease (ZVD) at KIMSHEALTH, Thiruvananthapuram, from 2021 to 2024. ZIKV infection was confirmed via ZIKV RT-PCR testing on patient samples.The study identified ten confirmed cases of ZVD in pregnant women. Clinical presentations included maculopapular rash (in all patients), fever, joint pain, non-purulent conjunctivitis, and myalgia. Among these, two infections near term resulted in normal fetal outcomes, one mid-trimester infection led to a normal delivery, six women opted for medical termination of pregnancy (MTP), and one woman experienced a miscarriage.</p><p><strong>Conclusion: </strong>The clinical features of ZVD during pregnancy observed in this cohort were similar to those in the general population. The absence of congenital anomalies suggests a potentially less pathogenic strain of ZIKV in India. However, further studies involving larger populations are required to conclusively determine the risk of congenital Zika syndrome in this region. This study underscores the need for ongoing surveillance and research to fully understand the impact of ZIKV on pregnancy in India.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 6","pages":"517-520"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12748434/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-10-09DOI: 10.1007/s13224-025-02207-4
Vittorio Unfer
{"title":"From Ovarian to Endocrine-Metabolic Roots: Aligning PCOS Nomenclature with Pathophysiology.","authors":"Vittorio Unfer","doi":"10.1007/s13224-025-02207-4","DOIUrl":"10.1007/s13224-025-02207-4","url":null,"abstract":"","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 6","pages":"527-528"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12748392/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-08-26DOI: 10.1007/s13224-025-02213-6
Ahmed Nofal, Dalia Morsi, Yousra Alghalban
Purpose: The aim of this study was to identify Maternal near miss cases among women admitted to Menoufia university hospitals, Obstetrics and Gynecology Department.
Methods: This cross-sectional study was conducted in Obstetrics and Gynecology Department, Menoufia University hospital. Egypt. (from the First of February 2023 to the end of January 2024). The study was approved by the ethical committee in the university. Information was collected from patients' files. A checklist was used to collect data from the hospital records of eligible cases.
Results: The study included 3392 participants: 3 maternal deaths and 260 Maternal Near-Miss cases. There were 3356 deliveries, 3328 live births. The MNM incidence ratio was 78.13 per 1000 live births and Maternal Mortality Ratio was 90.1/100 000 live births. Mortality Index was 1.1%. The leading causes of MNM 1-Obstetric causes: Uterine dysfunction, morbidly adherent placenta and Obstetric hemorrhage.2- Medical causes: Severe preeclampsia, and Neurologic dysfunction.
Conclusions and recommendations: MNM cases are relatively high in incidence relative to maternal mortality. Uterine dysfunction, morbidly adherent placenta, and obstetric hemorrhage were the main direct obstetric causes while the main medical causes were severe pre-eclampsia, neurological dysfunction and severe anemia. The main causes require strict and quick management protocols.
{"title":"Maternal Near-Miss Among Women Admitted to Menoufia University Hospital, Egypt.","authors":"Ahmed Nofal, Dalia Morsi, Yousra Alghalban","doi":"10.1007/s13224-025-02213-6","DOIUrl":"https://doi.org/10.1007/s13224-025-02213-6","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to identify Maternal near miss cases among women admitted to Menoufia university hospitals, Obstetrics and Gynecology Department.</p><p><strong>Methods: </strong>This cross-sectional study was conducted in Obstetrics and Gynecology Department, Menoufia University hospital. Egypt. (from the First of February 2023 to the end of January 2024). The study was approved by the ethical committee in the university. Information was collected from patients' files. A checklist was used to collect data from the hospital records of eligible cases.</p><p><strong>Results: </strong>The study included 3392 participants: 3 maternal deaths and 260 Maternal Near-Miss cases. There were 3356 deliveries, 3328 live births. The MNM incidence ratio was 78.13 per 1000 live births and Maternal Mortality Ratio was 90.1/100 000 live births. Mortality Index was 1.1%. The leading causes of MNM 1-Obstetric causes: Uterine dysfunction, morbidly adherent placenta and Obstetric hemorrhage.2- Medical causes: Severe preeclampsia, and Neurologic dysfunction.</p><p><strong>Conclusions and recommendations: </strong>MNM cases are relatively high in incidence relative to maternal mortality. Uterine dysfunction, morbidly adherent placenta, and obstetric hemorrhage were the main direct obstetric causes while the main medical causes were severe pre-eclampsia, neurological dysfunction and severe anemia. The main causes require strict and quick management protocols.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 6","pages":"500-505"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12748391/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-07-26DOI: 10.1007/s13224-025-02197-3
Krupa Shah, Shashikala Bhat, Vinutha Vinod, A P Ashwini, Rajeshwari Bhat
Background: Obesity is surging worldwide among all the age groups. As a result of obesity in reproductive-aged women, an increasing number of pregnancies are being detected with obesity. Optimal health is crucial for healthy mothers, foetuses and neonates. A high body mass index (BMI) poses a unique challenge to obstetricians. This study was conducted to identify the influence of maternal obesity on adverse pregnancy outcomes among nulliparous women with singleton pregnancies.
Methodology: A cohort of 642 pregnant women who delivered singleton babies between January 2022 and July 2024 was identified retrospectively. The body mass index was calculated in the first trimester and grouped as underweight, normal, overweight, obese (I), or obese (II) according to the Asia Pacific guidelines. Selected obstetric, perinatal and neonatal adverse outcomes were compared.
Results: Compared with pregnancies with a normal BMI, obese pregnancies were significantly more likely to have gestational diabetes mellitus (GDM), hypertension in pregnancy (HIP), caesarean delivery (CD) and macrosomia. Anaemia, low birth weight and growth restriction were less common in the obese group and more common in the underweight group. There was no significant association between threatened abortion, thyroid disorders and preterm deliveries in the study population. The odds of developing GDM were 2.3 (1.63-3.48) and 7.3 (3.79-14.26) for the HIP in the high BMI group. The risk of CD was 1.17 (0.46-2.98), and that of macrosomia was 2.26 (0.92-5.51) in the obese group.
Conclusion: Obesity during pregnancy is associated with a significant risk for the feto-maternal dyad. The risk of adverse outcomes increases with increasing obesity. The metabolic changes associated with obesity can be curtailed by physical activity and restriction of weight gain during pregnancy.
{"title":"Burden of Obesity in Nullipara with Singleton Pregnancy and Feto-Maternal Outcomes: A Retrospective Cohort Study From South India.","authors":"Krupa Shah, Shashikala Bhat, Vinutha Vinod, A P Ashwini, Rajeshwari Bhat","doi":"10.1007/s13224-025-02197-3","DOIUrl":"https://doi.org/10.1007/s13224-025-02197-3","url":null,"abstract":"<p><strong>Background: </strong>Obesity is surging worldwide among all the age groups. As a result of obesity in reproductive-aged women, an increasing number of pregnancies are being detected with obesity. Optimal health is crucial for healthy mothers, foetuses and neonates. A high body mass index (BMI) poses a unique challenge to obstetricians. This study was conducted to identify the influence of maternal obesity on adverse pregnancy outcomes among nulliparous women with singleton pregnancies.</p><p><strong>Methodology: </strong>A cohort of 642 pregnant women who delivered singleton babies between January 2022 and July 2024 was identified retrospectively. The body mass index was calculated in the first trimester and grouped as underweight, normal, overweight, obese (I), or obese (II) according to the Asia Pacific guidelines. Selected obstetric, perinatal and neonatal adverse outcomes were compared.</p><p><strong>Results: </strong>Compared with pregnancies with a normal BMI, obese pregnancies were significantly more likely to have gestational diabetes mellitus (GDM), hypertension in pregnancy (HIP), caesarean delivery (CD) and macrosomia. Anaemia, low birth weight and growth restriction were less common in the obese group and more common in the underweight group. There was no significant association between threatened abortion, thyroid disorders and preterm deliveries in the study population. The odds of developing GDM were 2.3 (1.63-3.48) and 7.3 (3.79-14.26) for the HIP in the high BMI group. The risk of CD was 1.17 (0.46-2.98), and that of macrosomia was 2.26 (0.92-5.51) in the obese group.</p><p><strong>Conclusion: </strong>Obesity during pregnancy is associated with a significant risk for the feto-maternal dyad. The risk of adverse outcomes increases with increasing obesity. The metabolic changes associated with obesity can be curtailed by physical activity and restriction of weight gain during pregnancy.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 6","pages":"494-499"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12748491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Antimicrobial resistance in sexually transmitted infection (STI) pathogens poses a persistent challenge, with resistant strains emerging even as new antibiotics are introduced. The aim of this study was to estimate the prevalence of STI pathogens and antibiotic resistance level in tribal women.
Materials and methods: Endocervical swab samples were collected from 110 women (aged ≤ 55). Multiplex real-time PCR was performed for the simultaneous detection of 08 STI pathogens in the target population. AST of commonly prescribed antibiotics was performed against most prevalent pathogens by Kirby-Bauer disk diffusion method. The statistical analysis was conducted using SPSS Statistics version 20.0.
Results: Out of 110, 85.45% of samples tested positive for at least one of the targeted eight STI pathogens. The most common pathogen was detected as Mycoplasma hominis in 67.27% samples followed by Ureaplasma urealyticum (59.09%), Ureaplasma parvum (33.64%), Trichomonas vaginalis(19.14%), Herpes simplex virus 1 & 2,(13.64%), Neisseria gonorrhoeae (8.18%), Mycoplasma genitalium (7.27%), and Chlamydia trachomatis (5.45%). The STIs were more prevalent in age groups 36-41. The antibiotic susceptibility test (AST) results showed that the multidrug-resistant (MDR) rate for Mycoplasma spp. was 100%, and that of Ureaplasma spp. was 45%.
Conclusion: The present study showed high frequency of STIs and antibiotic resistance in tribal populations. Real-time PCR is a vital tool for rapidly and accurately detecting STI pathogens, aiding in early and efficient diagnosis for better treatment outcomes. The alarming resistance patterns highlight the urgent need for targeted interventions and updated clinical guidelines to effectively address antimicrobial resistance (AMR) in Ureaplasma spp. and Mycoplasma spp. in this region.
{"title":"Multiplex Real-Time PCR-Based Rapid Detection of STI Pathogens and Antimicrobial Resistance Pattern of Prevalent Strains in Tribal Women of District Anuppur Madhya Pradesh.","authors":"Poonam Sharma, Juhi, Suraj Kumar Mishra, Rambir Singh","doi":"10.1007/s13224-025-02193-7","DOIUrl":"https://doi.org/10.1007/s13224-025-02193-7","url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial resistance in sexually transmitted infection (STI) pathogens poses a persistent challenge, with resistant strains emerging even as new antibiotics are introduced. The aim of this study was to estimate the prevalence of STI pathogens and antibiotic resistance level in tribal women.</p><p><strong>Materials and methods: </strong>Endocervical swab samples were collected from 110 women (aged ≤ 55). Multiplex real-time PCR was performed for the simultaneous detection of 08 STI pathogens in the target population. AST of commonly prescribed antibiotics was performed against most prevalent pathogens by Kirby-Bauer disk diffusion method. The statistical analysis was conducted using SPSS Statistics version 20.0.</p><p><strong>Results: </strong>Out of 110, 85.45% of samples tested positive for at least one of the targeted eight STI pathogens. The most common pathogen was detected <i>as Mycoplasma hominis</i> in 67.27% samples followed by <i>Ureaplasma urealyticum</i> (59.09%), <i>Ureaplasma parvum</i> (33.64%), <i>Trichomonas vaginalis</i>(19.14%), Herpes simplex virus 1 & 2,(13.64%), <i>Neisseria gonorrhoeae</i> (8.18%), <i>Mycoplasma genitalium</i> (7.27%), and <i>Chlamydia trachomatis</i> (5.45%). The STIs were more prevalent in age groups 36-41. The antibiotic susceptibility test (AST) results showed that the multidrug-resistant (MDR) rate for <i>Mycoplasma</i> spp. was 100%, and that of <i>Ureaplasma</i> spp. was 45%.</p><p><strong>Conclusion: </strong>The present study showed high frequency of STIs and antibiotic resistance in tribal populations. Real-time PCR is a vital tool for rapidly and accurately detecting STI pathogens, aiding in early and efficient diagnosis for better treatment outcomes. The alarming resistance patterns highlight the urgent need for targeted interventions and updated clinical guidelines to effectively address antimicrobial resistance (AMR) in <i>Ureaplasma</i> spp. and <i>Mycoplasma</i> spp. in this region.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 6","pages":"477-486"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12748318/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-08-07DOI: 10.1007/s13224-025-02172-y
P S Raji, Anitha Thomas, Dhanya Susan Thomas, Vinotha Thomas, Ajit Sebastian, G Banupriya, Sherin Daniel, Annie Jennifer
Introduction: Colposcopy remains the gold standard as a triage tool for evaluating pre-invasive cervical lesions. A colposcopy scoring system is introduced to minimize inter-observer variation. The National Health Service Cervical Screening Programme (NHSCSP), in collaboration with the British Society for Colposcopy and Cervical Pathology, has published guidelines covering various issues regarding quality assurance in cervical cancer prevention, including the standard requirements for colposcopy services. Our study aimed to assess the colposcopic quality standards and evaluate the concordance of colposcopic findings with cervical biopsy in a tertiary care institution.
Materials and methodology: Retrospective data are collected from electronic medical records and colposcopy registers over a period of 5 years (1st January 2018 - 31st December 2022). According to the NHS Cervical Screening Programme Colposcopy and Programme Guidelines 2016, Parameters were recorded. Results were analyzed using SPSS version 21.
Results: During the period of 5 years, 437 patients were identified. The mean age was 48.2±11 years. Cytology results were available in 431 (98.6%) women. The main indication of colposcopy was abnormal cervical cytology in 74.1% of patients. High-grade squamous intraepithelial lesion (HSIL) was seen in 20.4% of patients, and atypical squamous cells of unknown significance (ASCUS) in 21.3% of which 56.4% were human papillomavirus (HPV) positive.The colposcopic impression, type of transformation zone (TZ), and Swedes score were documented in 96.6%, 71.1%, and 96.3% cases, respectively. Biopsy was done in 388 (88.7%) patients (cervical intraepithelial neoplasia (CIN I) in 11.4%, CIN II-III in 26.6%, carcinoma in situ in 2.3%, and invasive cancer in 6.9%. The positive predictive value (PPV) of the Swedes' score in predicting lesions CIN2 or more was 64.5%. The correlation of the Swede's score <6 to low-grade biopsies (< CIN II) and score >6 to higher grade biopsies was fair, with a kappa coefficient of 0.3.
Conclusion: The subjective nature of colposcopy demands continued audit of individual practice to improve on areas found to be deficient. By using a standardized template for documentation and conducting regular audits, we can identify areas for improvement, better detection of pre-cancer lesions on colposcopy, and engage in continuous professional development.
引言:阴道镜检查仍然是评估侵袭前宫颈病变的鉴别工具的金标准。引入阴道镜评分系统,以尽量减少观察者之间的差异。国家保健服务子宫颈检查方案(NHSCSP)与英国阴道镜检查和宫颈病理学会合作,出版了涵盖有关宫颈癌预防质量保证的各种问题的指导方针,包括阴道镜检查服务的标准要求。本研究旨在评估一家三级医疗机构阴道镜检查的质量标准,并评估阴道镜检查结果与宫颈活检结果的一致性。材料和方法:回顾性数据从5年(2018年1月1日至2022年12月31日)的电子病历和阴道镜检查登记册中收集。根据2016年NHS宫颈筛查计划阴道镜检查和计划指南,记录参数。使用SPSS version 21对结果进行分析。结果:在5年的时间里,共发现437例患者。平均年龄48.2±11岁。431名(98.6%)女性有细胞学检查结果。74.1%的患者阴道镜检查主要指征为宫颈细胞学异常。20.4%的患者有高度鳞状上皮内病变(HSIL), 21.3%的患者有不明意义的非典型鳞状细胞(ASCUS),其中56.4%的患者有人乳头瘤病毒(HPV)阳性。阴道镜印型、转化区类型(TZ)和瑞典评分分别为96.6%、71.1%和96.3%。388例(88.7%)患者进行了活检(宫颈上皮内瘤变(CIN) 11.4%, CIN II-III型26.6%,原位癌2.3%,浸润性癌6.9%)。瑞典评分预测CIN2及以上病变的阳性预测值(PPV)为64.5%。瑞典人的6分与更高级别活检的相关性是公平的,kappa系数为0.3。结论:阴道镜检查的主观性要求对个人实践进行持续审核,以改进发现的不足之处。通过使用标准化的文件模板并进行定期审核,我们可以确定需要改进的领域,更好地检测阴道镜检查中的癌前病变,并进行持续的专业发展。
{"title":"Compliance to Standards of Colposcopy in an Effort to Reduce the Cervical Cancer Burden: An Audit.","authors":"P S Raji, Anitha Thomas, Dhanya Susan Thomas, Vinotha Thomas, Ajit Sebastian, G Banupriya, Sherin Daniel, Annie Jennifer","doi":"10.1007/s13224-025-02172-y","DOIUrl":"https://doi.org/10.1007/s13224-025-02172-y","url":null,"abstract":"<p><strong>Introduction: </strong>Colposcopy remains the gold standard as a triage tool for evaluating pre-invasive cervical lesions. A colposcopy scoring system is introduced to minimize inter-observer variation. The National Health Service Cervical Screening Programme (NHSCSP), in collaboration with the British Society for Colposcopy and Cervical Pathology, has published guidelines covering various issues regarding quality assurance in cervical cancer prevention, including the standard requirements for colposcopy services. Our study aimed to assess the colposcopic quality standards and evaluate the concordance of colposcopic findings with cervical biopsy in a tertiary care institution.</p><p><strong>Materials and methodology: </strong>Retrospective data are collected from electronic medical records and colposcopy registers over a period of 5 years (1st January 2018 - 31st December 2022). According to the NHS Cervical Screening Programme Colposcopy and Programme Guidelines 2016, Parameters were recorded. Results were analyzed using SPSS version 21.</p><p><strong>Results: </strong>During the period of 5 years, 437 patients were identified. The mean age was 48.2±11 years. Cytology results were available in 431 (98.6%) women. The main indication of colposcopy was abnormal cervical cytology in 74.1% of patients. High-grade squamous intraepithelial lesion (HSIL) was seen in 20.4% of patients, and atypical squamous cells of unknown significance (ASCUS) in 21.3% of which 56.4% were human papillomavirus (HPV) positive.The colposcopic impression, type of transformation zone (TZ), and Swedes score were documented in 96.6%, 71.1%, and 96.3% cases, respectively. Biopsy was done in 388 (88.7%) patients (cervical intraepithelial neoplasia (CIN I) in 11.4%, CIN II-III in 26.6%, carcinoma in situ in 2.3%, and invasive cancer in 6.9%. The positive predictive value (PPV) of the Swedes' score in predicting lesions CIN2 or more was 64.5%. The correlation of the Swede's score <6 to low-grade biopsies (< CIN II) and score >6 to higher grade biopsies was fair, with a kappa coefficient of 0.3.</p><p><strong>Conclusion: </strong>The subjective nature of colposcopy demands continued audit of individual practice to improve on areas found to be deficient. By using a standardized template for documentation and conducting regular audits, we can identify areas for improvement, better detection of pre-cancer lesions on colposcopy, and engage in continuous professional development.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 6","pages":"461-466"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12748386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-08-12DOI: 10.1007/s13224-025-02174-w
Keerti Dogra, Reema Khajuria, Ankita Sharma
Background: The prevalence of adnexal masses is 0.17% to 5.9% in asymptomatic and 7.1% to 12% in symptomatic patients. They can be benign or malignant. The initial detection and evaluation of an adnexal mass requires a high index of suspicion, a thorough history and examination and careful attention to subtle historical clues. Timely appropriate laboratory studies like serum cancer markers and radiographic studies are required to make a diagnosis, and finally, histopathological report tells us the exact nature of mass and guides further management.
Methodology: This prospective observational study was conducted in the Department of Obstetrics and Gynaecology, SMGS Hospital, GMC Jammu, over a period of one year from August 1st, 2023 to July 31st, 2024. The aim of this study was to determine the prevalence of adnexal masses with their related factors in this age group and to evaluate the adnexal mass in perimenopausal and postmenopausal age group. A total of 100 patients of adnexal masses with age > 40 years meeting inclusion and exclusion were included in the study. From all patients, history was obtained, clinical examination done followed by blood analysis, tumor markers, ultrasonography findings, CT and MRI findings of pelvic organs wherever applicable was done. Histopathological report was obtained.
Results: Adnexal mass was found to be more common in age group 40-50 years (48%). The usual presentation was with symptoms of abdominal pain (76%). Left-sided ovarian mass (41%) was more common than right-sided (32%) or bilateral masses (13%). USG 1 score was reported mostly in subjects with benign mass (67 out of 71), while USG 4 score was reported maximum among malignant mass (19 out of 29). CA-125 < 35 level was reported maximum among benign mass (68 out of 72), while > 35 level of CA-125 was reported maximum among malignant mass (19 out of 28). RMI < 200 was found mostly among benign mass (77 out of 79), while RMI > 200 was reported maximum in malignant mass (21 out of 21). In our study, each parameter when compared with histopathological report using kappa stats, results were found to be statistically significant (p < 0.05). Benign masses were present in 64.2% cases and malignant masses were present in 35.8% cases in perimenopausal age group and 33.3% benign and 66.7% malignant cases were present in postmenopausal age group.
Conclusion: Ultrasound and CA-125 are important adjuvants which play vital role in the diagnosis and treatment of adnexal masses in perimenopausal and post-menopausal women. RMI and histopathology findings are in positive correlation. Therefore, it can be concluded that RMI can be used for evaluation of adnexal mass preoperatively and thus guides further management.
{"title":"Evaluation of Adnexal Masses in Perimenopausal and Postmenopausal Females-A One-year Prospective Observational Study.","authors":"Keerti Dogra, Reema Khajuria, Ankita Sharma","doi":"10.1007/s13224-025-02174-w","DOIUrl":"https://doi.org/10.1007/s13224-025-02174-w","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of adnexal masses is 0.17% to 5.9% in asymptomatic and 7.1% to 12% in symptomatic patients. They can be benign or malignant. The initial detection and evaluation of an adnexal mass requires a high index of suspicion, a thorough history and examination and careful attention to subtle historical clues. Timely appropriate laboratory studies like serum cancer markers and radiographic studies are required to make a diagnosis, and finally, histopathological report tells us the exact nature of mass and guides further management.</p><p><strong>Methodology: </strong>This prospective observational study was conducted in the Department of Obstetrics and Gynaecology, SMGS Hospital, GMC Jammu, over a period of one year from August 1st, 2023 to July 31st, 2024. The aim of this study was to determine the prevalence of adnexal masses with their related factors in this age group and to evaluate the adnexal mass in perimenopausal and postmenopausal age group. A total of 100 patients of adnexal masses with age > 40 years meeting inclusion and exclusion were included in the study. From all patients, history was obtained, clinical examination done followed by blood analysis, tumor markers, ultrasonography findings, CT and MRI findings of pelvic organs wherever applicable was done. Histopathological report was obtained.</p><p><strong>Results: </strong>Adnexal mass was found to be more common in age group 40-50 years (48%). The usual presentation was with symptoms of abdominal pain (76%). Left-sided ovarian mass (41%) was more common than right-sided (32%) or bilateral masses (13%). USG 1 score was reported mostly in subjects with benign mass (67 out of 71), while USG 4 score was reported maximum among malignant mass (19 out of 29). CA-125 < 35 level was reported maximum among benign mass (68 out of 72), while > 35 level of CA-125 was reported maximum among malignant mass (19 out of 28). RMI < 200 was found mostly among benign mass (77 out of 79), while RMI > 200 was reported maximum in malignant mass (21 out of 21). In our study, each parameter when compared with histopathological report using kappa stats, results were found to be statistically significant (<i>p</i> < 0.05). Benign masses were present in 64.2% cases and malignant masses were present in 35.8% cases in perimenopausal age group and 33.3% benign and 66.7% malignant cases were present in postmenopausal age group.</p><p><strong>Conclusion: </strong>Ultrasound and CA-125 are important adjuvants which play vital role in the diagnosis and treatment of adnexal masses in perimenopausal and post-menopausal women. RMI and histopathology findings are in positive correlation. Therefore, it can be concluded that RMI can be used for evaluation of adnexal mass preoperatively and thus guides further management.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 6","pages":"467-471"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12748376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Coexistence of Abdomino-pelvic Tuberculosis and Ovarian Malignancy: A Rare Entity.","authors":"Kavita Khoiwal, Divya Reddy, Akash Dhiman, Parish Kamdi, Jaya Chaturvedi","doi":"10.1007/s13224-025-02218-1","DOIUrl":"https://doi.org/10.1007/s13224-025-02218-1","url":null,"abstract":"","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 6","pages":"521-523"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12748442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-12-23DOI: 10.1007/s13224-025-02334-y
Sujata Dalvi
{"title":"Global Editorial Convergence: JOGI Connects with Medical Journals Across Borders.","authors":"Sujata Dalvi","doi":"10.1007/s13224-025-02334-y","DOIUrl":"https://doi.org/10.1007/s13224-025-02334-y","url":null,"abstract":"","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 6","pages":"453-456"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12748401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}